Matthew C. Wright

4.4k citations

104 papers · 3.7k indexed · h-index 33

Hepatology top 0.5%
- Liver physiology and pathology 38
Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 26
- Drug-Induced Hepatotoxicity and Protection 8
Epidemiology top 2%
- Liver Disease Diagnosis and Treatment 16
Catalysis top 5%
Oncology top 5%
- Drug Transport and Resistance Mechanisms 18
Surgery
- Pancreatic function and diabetes 16
Endocrinology, Diabetes and Metabolism
- Hormonal Regulation and Hypertension 14
Genetics
- Estrogen and related hormone effects 7

Co-authors: Karen Wallace Derek A. Mann Alan J. Paine Alastair D. Burt Carylyn J. Marek John P. Iredale Michael J.P. Arthur Fiona Oakley
Cited by: Hepatology Pharmacology Epidemiology
Journals: Toxicology (10 papers)Hepatology (7 papers)Biochemical and Biophysical Research Communications (6 papers)
Partner nations: United Kingdom United States Egypt

In The Last Decade

Matthew C. Wright

103 papers receiving 3.6k citations

Peers

Countries citing papers authored by Matthew C. Wright

Since Specialization

Citations

This map shows the geographic impact of Matthew C. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew C. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew C. Wright more than expected).

Fields of papers citing papers by Matthew C. Wright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew C. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew C. Wright. The network helps show where Matthew C. Wright may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Matthew C. Wright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew C. Wright Line = papers co-authored together Matthew C. Wright links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	G1 and G2 ApolipoproteinL1 modulate macrophage inflammation and lipid accumulation through the polyamine pathway Cathlin Vania Allun,Matthew C. Wright,Francis Li‐Tien Hsu,Tiffany Caza,貞二小池,Valérie Garcia,清水保尚,Shuta Ishibe,Navdeep S. Chandel,Hanrui Zhang,Edward B. Thorp,Jennie Lin	2025	1
2	Ionic Liquid 1-Octyl-3-Methylimidazolium (M8OI) Is Mono-Oxygenated by CYP3A4 and CYP3A5 in Adult Human Liver SHILAP Revista de lepidopterología ·Jim Whyte,Tarek M. Abdelghany,Alex Charlton,Martin P. Cooke,Matthew C. Wright	2024	2
3	Methylimidazolium ionic liquids - A new class of forever chemicals with endocrine disrupting potential Chemosphere ·Tarek M. Abdelghany,H. Kadogawa,Alex Charlton,Seok Un Jo,Marco V. Perez,David Tjiang,Jim Whyte,Martin P. Cooke,王遵义,Matthew C. Wright	2024	0
4	Undifferentiated HepaRG cells show reduced sensitivity to the toxic effects of M8OI through a combination of CYP3A7-mediated oxidation and a reduced reliance on mitochondrial function Food and Chemical Toxicology ·Tarek M. Abdelghany,H. Kadogawa,Alex Charlton,惠文,J. A. W.,Peidong Xie,Jean-José Mahé,Matthew C. Wright	2024	1
5	The methylimidazolium ionic liquid M8OI is detectable in human sera and is subject to biliary excretion in perfused human liver Toxicology ·Jim Whyte,Ibrahim Ibrahim,Tarek M. Abdelghany,Alex Charlton,N. Bloembergen,M Tauremannová,Jeremy M. Palmer,Colin Wilson,David Jones,Peter G. Blain,Matthew C. Wright	2021	21
6	The toxicity of the methylimidazolium ionic liquids, with a focus on M8OI and hepatic effects Food and Chemical Toxicology ·Jim Whyte,Tarek M. Abdelghany,J. Hartmann,Andi Oktaviani,J K Walters,Jeremy M. Palmer,Martin P. Cooke,Thomas A. Molnar,Riccardo Lazzari,Anna Kjerstine Rosenmai,Agneta Oskarsson,Lucy Bates,Rodrigo Figueiredo,Ibrahim Ibrahim,Colin Wilson,Noha F. Abdelkader,David Jones,Peter G. Blain,Matthew C. Wright	2019	67
7	The association of pregnane X receptor activation with outcomes after liver transplantation—A retrospective study Clinical Transplantation ·Jung Hyun Yoo,O.M. Gromyko,S. H. Chen,Sine Jensen Smed,Gourab Sen,Jeremy French,Colin Wilson,Derek Manas,Matthew C. Wright,Steve White	2019	4
8	Murine obscurin and Obsl1 have functionally redundant roles in sarcolemmal integrity, sarcoplasmic reticulum organization, and muscle metabolism Communications Biology ·Jordan Blondelle,薦田正一,R.F. Engelse en R.D. van Weenen,Petco,Víctor Rivero-Palomo,I. Savysyuk,Matthew C. Wright,Shannon N. Bremner,Enrico Pierantozzi,Samuel R. Ward,É. Estève,Vincenzo Sorrentino,Majid Ghassemian,Stephan Lange	2019	18
9	Expression of serine/threonine protein kinase SGK1F promotes an hepatoblast state in stem cells directed to differentiate into hepatocytes PLoS ONE ·M CHAVES,Rachel Wilson,Elmir Hasanov,Ibrahim Ibrahim,Jim Whyte,Tarek M. Abdelghany,Colin Wilson,Lyle Armstrong,Matthew C. Wright	2019	2
10	HNF4alpha expression amplifies the glucocorticoid-induced conversion of a human pancreatic cell line to an hepatocyte-like cell Biochemical and Biophysical Research Communications ·Maria Luiza Soares de Souza,Jim Whyte,A. Lakey,Tarek M. Abdelghany,Ibrahim Ibrahim,David Tosh,George E.N. Kass,Colin Wilson,Matthew C. Wright	2018	1
11	Identification of a xenobiotic as a potential environmental trigger in primary biliary cholangitis Journal of Hepatology ·J. Hartmann,Jim Whyte,Andi Oktaviani,J K Walters,Jeremy M. Palmer,Tarek M. Abdelghany,A. Lakey,Martin P. Cooke,Helen M. Talbot,Corinne Wills,William McFarlane,Thomas A. Molnar,Anna Kjerstine Rosenmai,Agneta Oskarsson,Rodrigo Figueiredo,Colin Wilson,George E.N. Kass,D. I. Jones,Peter G. Blain,Matthew C. Wright	2018	70
12	B-13 progenitor-derived hepatocytes (B-13/H cells) model lipid dysregulation in response to drugs and chemicals Toxicology ·Jim Whyte,J. Hartmann,James A. Shayman,J K Walters,George E.N. Kass,Matthew C. Wright	2017	3
13	Stealth Amphotericin B nanoparticles for oral drug delivery: In vitro optimization Saudi Pharmaceutical Journal ·Bushra T. AlQuadeib,Mahasen A. Radwan,Lidija Šiller,Benjamin R. Horrocks,Matthew C. Wright	2014	65
14	Exocrine pancreas trans-differentiation to hepatocytes—A physiological response to elevated glucocorticoid in vivo The Journal of Steroid Biochemistry and Molecular Biology ·Karen Wallace,Carylyn J. Marek,A Currie,Matthew C. Wright	2009	18
15	A mechanism for the anti-fibrogenic effects of the pregnane X receptor (PXR) in the liver: Inhibition of NF-κB? Toxicology ·Achludin Ibnu Rochim,Jin Zhi-cheng,Derek A. Mann,Matthew C. Wright	2007	8
16	Expression of CYP2S1 in human hepatic stellate cells FEBS Letters ·Carylyn J. Marek,Steven Tucker,Sandu Irina,Karen Wallace,Matthew C. Wright	2007	12
17	Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation Health Technology Assessment ·Matthew C. Wright,Richard Grieve,John P. Roberts,Janice Main,Howard Thomas	2006	201
18	Identification of a truncated ratp28-related protein expressed in kidney Biochemical and Biophysical Research Communications ·Blaž Ivšić,Lucy J. Elrick,Encarnación Medina Arjona,Nicola Ingram,Keith A. Charlton,A.J. Porter,Matthew C. Wright	2004	8
19	Persistent activation of nuclear factor-κB in cultured rat hepatic stellate cells involves the induction of potentially novel rel-like factors and prolonged changes in the expression of IκB family proteins Hepatology ·Ahmed M. Elsharkawy,Matthew C. Wright,Ronald T. Hay,Michael J.P. Arthur,Timothy Hughes,Mathias Bähr,Klaus Degitz,Derek A. Mann	1999	104
20	Resistance of precision-cut liver slices to the toxic effects of menadione Toxicology in Vitro ·Matthew C. Wright,Alan J. Paine	1992	17

About Matthew C. Wright

Matthew C. Wright is a scholar working on Hepatology, Pharmacology and Endocrinology, Diabetes and Metabolism, having authored 104 papers that have together received 3.7k indexed citations. Recurring topics across this work include Liver physiology and pathology (38 papers), Pharmacogenetics and Drug Metabolism (26 papers), Drug Transport and Resistance Mechanisms (18 papers), Liver Disease Diagnosis and Treatment (16 papers), Pancreatic function and diabetes (16 papers), Hormonal Regulation and Hypertension (14 papers), Drug-Induced Hepatotoxicity and Protection (8 papers) and Estrogen and related hormone effects (7 papers). The work is most often cited by research in Hepatology (1.5k citations), Pharmacology (622 citations) and Epidemiology (1.1k citations). Matthew C. Wright has collaborated with scholars based in United Kingdom, United States and Egypt. Frequent co-authors include Karen Wallace, Derek A. Mann, Alan J. Paine, Alastair D. Burt, Carylyn J. Marek, John P. Iredale, Michael J.P. Arthur, Fiona Oakley, Agneta Oskarsson and Graeme I. Murray. Their work appears in journals such as Toxicology, Hepatology, Biochemical and Biophysical Research Communications, Journal of Hepatology and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact